STOCK TITAN

Vanguard disaggregates holdings; reports 0 shares for Natera (NTRA)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Natera Inc — Schedule 13G/A (Amendment No. 7): The Vanguard Group reports no beneficial ownership. The filing states 0 shares beneficially owned, representing 0% of the class as disclosed in the amendment. The filing explains an internal realignment effective January 12, 2026, causing separate reporting by certain Vanguard subsidiaries.

Positive

  • None.

Negative

  • None.

Insights

Vanguard disaggregation yields a zero beneficial ownership disclosure for Natera.

The amendment shows 0 shares and 0% ownership as reported by The Vanguard Group following an internal realignment described in the filing dated January 12, 2026. The text cites SEC Release No. 34-39538 as the basis for separate subsidiary reporting.

Practical implications depend on how Vanguard's subsidiaries now report positions; subsequent filings by those entities may show beneficial holdings. Cash‑flow treatment and any subsidiary holdings are not specified in this excerpt.






632307104

(CUSIP Number)
03/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

What does The Vanguard Group report for NTRA ownership?

The filing reports 0 shares beneficially owned, representing 0% of the class. The amendment notes Vanguard underwent an internal realignment on January 12, 2026, after which certain subsidiaries report holdings separately under SEC Release No. 34-39538.

Does this Schedule 13G/A mean Vanguard holds no economic interest in NTRA?

The filing states 0 shares beneficially owned by The Vanguard Group itself and 0% ownership. It also explains subsidiaries now report separately; economic interests may exist under subsidiary filings, which are not included in this excerpt.

Why did Vanguard change its reporting for Natera (NTRA)?

Vanguard describes an internal realignment effective January 12, 2026 and cites SEC Release No. 34-39538, which permits disaggregated reporting by subsidiaries or business divisions. The amendment says those entities will report separately from The Vanguard Group, Inc.

Who signed the amended Schedule 13G/A for NTRA?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, on March 27, 2026. The signature block lists The Vanguard Group as the reporting person and provides the Malvern, PA address for the filer.

Will this filing affect Natera shareholder votes or dividends?

This filing only reports beneficial ownership as 0 shares for The Vanguard Group and does not state any change to voting or dividend rights. Any voting or dividend authority held by Vanguard subsidiaries would be disclosed in their separate filings, not in this excerpt.
Natera Inc

NASDAQ:NTRA

View NTRA Stock Overview

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

27.80B
136.75M
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN